NMPA Approval

Omeprazole and Sodium Bicarbonate for Suspension（Ⅰ）

Approval Number

国药准字H20253244

Company山东益康药业股份有限公司

Registration Date

January 24, 2025

Drug Information

Generic Name

奥美拉唑碳酸氢钠干混悬剂(Ⅰ)

Dosage Form

口服混悬剂

Strength

每袋含奥美拉唑20mg与碳酸氢钠1680mg

Drug Type

化学药品

Registration Date

January 24, 2025

Company Information

Applicant Company

Company Name山东益康药业股份有限公司

Company Address

山东省滕州市益康大道3288号

Manufacturing Company

Company Name山东益康药业股份有限公司

Company Address

山东省滕州市益康大道3288号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美拉唑碳酸氢钠干混悬剂(Ⅰ) - NMPA 批准文号 | MedPath